5 Key Takeaways
-
1
Preservative-free compounded drops improve tolerability, adherence, and affordability for glaucoma patients.
-
2
Benzalkonium chloride (BAK) in glaucoma therapies causes significant ocular surface issues and reduces patient comfort.
-
3
Fixed-combination compounded drops simplify treatment regimens, especially for patients requiring multiple IOP-lowering medications.
-
4
Compounded drops eliminate insurance-related delays, making them accessible and cost-effective for patients.
-
5
Integrating preservative-free compounded therapy into glaucoma care enhances patient quality of life and treatment adherence.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.